Kevin W. Garey, PharmD, MS, FIDSA, FASHP

University of Houston

Disclosure(s): Acurx: Grant/Research Support; Merck & Co.: Grant/Research Support; Paratek Pharmaceuticals: Grant/Research Support

Poster(s):

• (P-1020) Real-World Effectiveness and Health-Related Quality of Life Improvements Using Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1210) Real-World Efficacy and Safety of Meropenem-Vaborbactam in Patients with Moderate to Severe Renal Impairment
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET